196 related articles for article (PubMed ID: 22674913)
1. Characteristics of pelvic lymph node metastases in prostatic adenocarcinoma: a study of 83 cases.
Yoon JY; Kryvenko ON; Ghani KR; Bertucci C; Menon M; Gupta NS
Int J Surg Pathol; 2012 Oct; 20(5):449-54. PubMed ID: 22674913
[TBL] [Abstract][Full Text] [Related]
2. Total submission of pelvic lymphadenectomy tissues removed during radical prostatectomy for prostate cancer increases lymph node yield and detection of micrometastases.
Perry-Keene J; Ferguson P; Samaratunga H; Nacey JN; Delahunt B
Histopathology; 2014 Feb; 64(3):399-404. PubMed ID: 24118022
[TBL] [Abstract][Full Text] [Related]
3. Lymph node count threshold for optimal pelvic lymph node staging in prostate cancer.
Abdollah F; Sun M; Thuret R; Jeldres C; Tian Z; Briganti A; Shariat SF; Perrotte P; Montorsi F; Karakiewicz PI
Int J Urol; 2012 Jul; 19(7):645-51. PubMed ID: 22416788
[TBL] [Abstract][Full Text] [Related]
4. The influence of lymph node counts on the detection of pelvic lymph node metastasis in prostate cancer.
Barth PJ; Gerharz EW; Ramaswamy A; Riedmiller H
Pathol Res Pract; 1999; 195(9):633-6. PubMed ID: 10507083
[TBL] [Abstract][Full Text] [Related]
5. Anatomical extent of pelvic lymphadenectomy in patients undergoing radical prostatectomy.
Heidenreich A; Ohlmann CH; Polyakov S
Eur Urol; 2007 Jul; 52(1):29-37. PubMed ID: 17448592
[TBL] [Abstract][Full Text] [Related]
6. Detailed analysis of patients with metastasis to the prostatic anterior fat pad lymph nodes: a multi-institutional study.
Kim IY; Modi PK; Sadimin E; Ha YS; Kim JH; Skarecky D; Cha DY; Wambi CO; Ou YC; Yuh B; Park S; Llukani E; Albala DM; Wilson T; Ahlering T; Badani K; Ahn H; Lee DI; May M; Kim WJ; Lee DH
J Urol; 2013 Aug; 190(2):527-34. PubMed ID: 23485503
[TBL] [Abstract][Full Text] [Related]
7. Current status of pelvic lymph node dissection in prostate cancer: the New York PLND nomogram.
Kazzazi A; Djavan B
Can J Urol; 2011 Apr; 18(2):5585-91. PubMed ID: 21504645
[TBL] [Abstract][Full Text] [Related]
8. Nodal counts during pelvic lymph node dissection for prostate cancer: an objective indicator of quality under the influence of very subjective factors.
Mazzola C; Savage C; Ahallal Y; Reuter VE; Eastham JA; Scardino PT; Guillonneau B; Touijer KA
BJU Int; 2012 May; 109(9):1323-8. PubMed ID: 21992661
[TBL] [Abstract][Full Text] [Related]
9. Transforming growth factor-beta 1: comparative immunohistochemical localization in human primary and metastatic prostate cancer.
Eastham JA; Truong LD; Rogers E; Kattan M; Flanders KC; Scardino PT; Thompson TC
Lab Invest; 1995 Nov; 73(5):628-35. PubMed ID: 7474936
[TBL] [Abstract][Full Text] [Related]
10. Assessment of rates of lymph nodes and lymph node metastases in periprostatic fat pads in a consecutive cohort treated with retropubic radical prostatectomy.
Hansen J; Budäus L; Spethmann J; Schlomm T; Salomon G; Rink M; Haese A; Steuber T; Heinzer H; Huland H; Graefen M; Michl U
Urology; 2012 Oct; 80(4):877-82. PubMed ID: 22950996
[TBL] [Abstract][Full Text] [Related]
11. [The role of pelvic lymphadenectomy in the therapy of prostate and bladder cancer].
Heidenreich A; Ohlmann CH
Aktuelle Urol; 2005 Jun; 36(3):219-29. PubMed ID: 16001337
[TBL] [Abstract][Full Text] [Related]
12. Seminal vesicle biopsy and laparoscopic pelvic lymph node dissection: implications for patient selection in the radiotherapeutic management of prostate cancer.
Stock RG; Stone NN; Ianuzzi C; Unger P
Int J Radiat Oncol Biol Phys; 1995 Nov; 33(4):815-21. PubMed ID: 7591888
[TBL] [Abstract][Full Text] [Related]
13. Comparison of proliferating cell nuclear antigen immunostaining in lymph node metastases and primary prostate adenocarcinoma after neoadjuvant androgen deprivation therapy.
Minardi D; Galosi AB; Giannulis I; Montironi R; Polito M; Muzzonigro G
Scand J Urol Nephrol; 2004; 38(1):19-25. PubMed ID: 15204422
[TBL] [Abstract][Full Text] [Related]
14. Robotic extended pelvic lymphadenectomy for intermediate- and high-risk prostate cancer.
Yuh BE; Ruel NH; Mejia R; Wilson CM; Wilson TG
Eur Urol; 2012 May; 61(5):1004-10. PubMed ID: 22366188
[TBL] [Abstract][Full Text] [Related]
15. Radioisotope guided sentinel lymph node dissection in patients with localized prostate cancer: results of the first 100 cases.
Bastide C; Brenot-Rossi I; Garcia S; Rossi D
Eur J Surg Oncol; 2009 Jul; 35(7):751-6. PubMed ID: 18538526
[TBL] [Abstract][Full Text] [Related]
16. The impact of robotic surgery on pelvic lymph node dissection during radical prostatectomy for localized prostate cancer: the Brown University early robotic experience.
Yates J; Haleblian G; Stein B; Miller B; Renzulli J; Pareek G
Can J Urol; 2009 Oct; 16(5):4842-6. PubMed ID: 19796462
[TBL] [Abstract][Full Text] [Related]
17. Implications of prostate micrometastases in pelvic lymph nodes: an archival tissue study.
Edelstein RA; Zietman AL; de las Morenas A; Krane RJ; Babayan RK; Dallow KC; Traish A; Moreland RB
Urology; 1996 Mar; 47(3):370-5. PubMed ID: 8633404
[TBL] [Abstract][Full Text] [Related]
18. [Clinical outcome of radical prostatectomy and pelvic lymph node dissection].
Mizutani K; Ono Y; Kato N; Takeda A; Yamada S; Kinukawa T; Hattori R; Sahashi M; Matsuura O; Takeuchi N
Hinyokika Kiyo; 1995 Nov; 41(11):867-71. PubMed ID: 8533688
[TBL] [Abstract][Full Text] [Related]
19. Analysis of regional lymph nodes in periprostatic fat following robot-assisted radical prostatectomy.
Yuh B; Wu H; Ruel N; Wilson T
BJU Int; 2012 Feb; 109(4):603-7. PubMed ID: 21851536
[TBL] [Abstract][Full Text] [Related]
20. Lymph node metastases of prostatic adenocarcinoma in the mesorectum in patients with adenocarcinoma or villous tumor of the rectum with collision phenomenon in a single lymph node: report of five cases.
Mourra N; Parc Y; McNamara D; Tiret E; Flejou JF; Parc R
Dis Colon Rectum; 2005 Feb; 48(2):384-9. PubMed ID: 15812588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]